Olympus Corp (7733) - Financial and Strategic SWOT Analysis Review

Olympus Corp (7733) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Olympus Corp (Olympus) is a medical technology company. It develops, manufactures, and commercializes equipment and devices for medical, healthcare, imaging, information, and other industrial markets. Olympus' major products include endoscopes, laparoscopes, video imaging systems, surgical energy devices, and instruments for disease prevention, detection, and treatment. The company’s products find application across various medical fields including endotherapy, respiratory, urology, gynecology, ear, nose, and throat, and surgical devices. It also offers biomedical materials and system development services. The company has an operational presence in the Americas, Europe, and Asia-Pacific. Olympus Corp is headquartered in Hachioji-shi, Tokyo, Japan.Olympus Corp Key Recent Developments

Aug 07,2024: Olympus : Notice Concerning Change of Executive Officers
Jun 12,2024: Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India
May 01,2024: Launch of New True to Life Story That Introduces a New Initiative Using Digital Technologies to Address Challenges In Local Gastric Cancer Screenings
Apr 22,2024: Odin Vision Leveraged Nvidia Inception Program for Startups to Build Cloud-Connected AI Models to Support Endoscopy

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Olympus Corp - Key Facts
Olympus Corp - Key Employees
Olympus Corp - Key Employee Biographies
Olympus Corp - Major Products and Services
Olympus Corp - History
Olympus Corp - Company Statement
Olympus Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Olympus Corp - Business Description
Business Segment: Endoscopic Solutions
Overview
Performance
Business Segment: Others
Overview
Performance
Business Segment: Therapeutic Solutions
Overview
Performance
Geographical Segment: Asia and Oceania
Target Markets
Performance
Geographical Segment: China
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Japan
Performance
Geographical Segment: North America
Target Markets
Performance
Geographical Segment: Others
Target Markets
Performance
R&D Overview
Olympus Corp - Corporate Strategy
Olympus Corp - SWOT Analysis
SWOT Analysis - Overview
Olympus Corp - Strengths
Olympus Corp - Weaknesses
Olympus Corp - Opportunities
Olympus Corp - Threats
Olympus Corp - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Olympus Corp, Medical Equipment, Deals By Year, 2018 to YTD 2024
Olympus Corp, Medical Equipment, Deals By Type, 2018 to YTD 2024
Olympus Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 07, 2024: Olympus : Notice Concerning Change of Executive Officers
Jun 12, 2024: Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India
May 01, 2024: Launch of New True to Life Story That Introduces a New Initiative Using Digital Technologies to Address Challenges In Local Gastric Cancer Screenings
Apr 22, 2024: Odin Vision Leveraged Nvidia Inception Program for Startups to Build Cloud-Connected AI Models to Support Endoscopy
Apr 19, 2024: Apr. 19, 2024 Corporate New Installment in True to Life Story Series Features Olympus Korea Corporate Social Responsibility Initiative “Going on Campaign”
Mar 27, 2024: Olympus Partners with American Lung Association on Patient Education for Lung Cancer Screening
Mar 27, 2024: NTT and Olympus Begin World’s First Joint Demonstration Experiment of Cloud Endoscopy System
Nov 13, 2023: Olympus Corp Announces Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2024
Oct 03, 2023: Olympus Names Dr. John de Csepel as Chief Medical Officer
Sep 12, 2023: Olympus Adopts AcuityMD Across the Enterprise to Power an Expanding Omnichannel Engagement Strategy
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Olympus Corp, Key Facts
Olympus Corp, Key Employees
Olympus Corp, Key Employee Biographies
Olympus Corp, Major Products and Services
Olympus Corp, History
Olympus Corp, Other Locations
Olympus Corp, Subsidiaries
Olympus Corp, Key Competitors
Olympus Corp, Ratios based on current share price
Olympus Corp, Annual Ratios
Olympus Corp, Annual Ratios (Cont...1)
Olympus Corp, Annual Ratios (Cont...2)
Olympus Corp, Interim Ratios
Olympus Corp, Medical Equipment, Deals By Year, 2018 to YTD 2024
Olympus Corp, Medical Equipment, Deals By Type, 2018 to YTD 2024
Olympus Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Olympus Corp, Performance Chart (2020 - 2024)
Olympus Corp, Ratio Charts
Olympus Corp, Medical Equipment, Deals By Year, 2018 to YTD 2024
Olympus Corp, Medical Equipment, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings